by GlobeNewsWire | Aug 15, 2016 | Globe Newswire
ROSELAND, N.J., Aug. 15, 2016 (GLOBE NEWSWIRE) — Emisphere Technologies, Inc. (OTCBB:EMIS) today reported financial results for the second quarter ended June 30, 2016, and provided an overview of corporate accomplishments and plans. “During the first half of...
by GlobeNewsWire | Aug 8, 2016 | Globe Newswire
ROSELAND, N.J., Aug. 08, 2016 (GLOBE NEWSWIRE) — Emisphere Technologies, Inc. (OTCBB:EMIS) announced today that management will host a conference call to discuss the Company’s financial and operational results for the three months ended June 30, 2016, on...
by GlobeNewsWire | Mar 29, 2016 | Globe Newswire
ROSELAND, N.J., March 29, 2016 (GLOBE NEWSWIRE) — Emisphere Technologies, Inc. (OTCBB:EMIS) today reported financial results for the fourth quarter and full fiscal year ended December 31, 2015, and provided an overview of corporate accomplishments and plans....
by GlobeNewsWire | Nov 16, 2015 | Globe Newswire
ROSELAND, N.J., Nov. 16, 2015 (GLOBE NEWSWIRE) — Emisphere Technologies, Inc. (OTCBB:EMIS) today reported financial results for the third quarter ended September 30, 2015, and provided a corporate update. “During the third quarter, we made great strides in...
by GlobeNewsWire | Aug 26, 2015 | Globe Newswire
ROSELAND, N.J., Aug. 26, 2015 (GLOBE NEWSWIRE) — Emisphere Technologies, Inc. (OTCBB:EMIS) today highlighted that Eligen® licensee Novo Nordisk A/S (NYSE:NVO) will initiate a global phase 3a development program with oral semaglutide, a once daily oral...